Personalized Medicine and the Future of Pathology at Penn Medicine

Personalized Medicine and the Future of Pathology at Penn Medicine

David B. Roth, MD, PhD, offers an overview of the Center for Personalized Diagnostics (CPD), where pathologists are performing large-scale, massively parallel DNA sequencing and chromosomal analysis to identify genomic alterations in hematologic and solid tumor cancers. The CPD is a joint effort of Penn Medicine and the Abramson Cancer Center.

 

 

Related Links


Published

August 14, 2014

Created by

Penn Physician VideoLink